A prominent cancer site network in Michigan has teamed up with Rockville, Md., venture studio Hibiscus BioVentures on the clinical development of novel cancer treatments.

The Barbara Ann Karmanos Cancer Institute will provide Hibiscus and its portfolio companies with clinical resources, including laboratory/research access, scientific expertise and clinical research strategy support, to deliver new cancer therapies.

The institute is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers nationwide. It consists of 15 network sites located across Michigan that conduct clinical research and deliver care.